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HLA-A, -B positive sera of south Indian parous women were screened for the
presence of HLA-DR and -DQ antibodies. The sera were absorbed with pooled
platelets in a micro-method and screened against HLA-DR and -DQ typed B-lym-
phocytes panel.Out of fifty two sera, twenty were found to contain HLA-DR and -DQ
   antibodies. Seven sera were demonstrated to be specific for well defined DR and
The HLA (Human Leucocyte Antigen) com-
plex has been localized to the short arm of the
chromosome number 6 in the distal portion of 6p
21.3 band. This complex consists of at least
seven well estimated loci which are designated
as HLA-A, -B, -C, -D, -DR, -DQ and -DP. HLA-A,
-B and -C antigens are known as class I antigens
and HLA-D, -DR, -DQ and -DP antigens are
known as class II antigens (1).
HLA-phenotyping of class I and some class
II antigens is being carried out by serological
typing method using allospecific human antisera
and HLA-genotyping by restriction fragment
length polymorphism (RFLP) using DNA probes
for the HLA region of the human genome (2)
and/or polymerase chain reaction (PCR)
amplified human DNA (HLA genome) with se-
quence specific oligonucleotide (SSO) probes (3).
It has been well established that the sera of
pregnant women are the most suitable and easily
obtainable source for HLA antibodies. Further,
it is evident that HLA-A, -B, -C antisera also
frequently contain anti-HLA -DR (and -DQ) an-
tibodies; specific -DR (and -DQ) antisera without
MA-ABC antibodies have also been observed
though rarely (4 - 6). In our earlier reports (7, 8),
data on the screening for HLA-A, -B (class I)
antibodies in the sera of South Indian parous
women were presented. In the present study
HLA-A, -B (class I) positive sera of the previous
tudies were screened for the presence of HLA-
DR and -DQ (class- II) antibodies and the results
are discussed.
Materials and Methods
(i) Collection of parous women sera
Postpartum Mood dots were collected im-
mediately after delivery (primiparous and multi-
parous) and the sera were separated and stored
at -90ºC as described elsewhere (7,9).
(ii) Screening of sera for HLA-A. -B
antibodies
A total number of 1161 sera were screened
against HLA-A, -B typed cell panel members and
the results have been published in our earlier
reports (7,8).
(iii) Screening of sera for HLA-DR
and -DQ antibodies
The HLA-A, -B positive sera were screened
for the presence of HLA-DR, and -DQ antibodies
against 32 normal individuals.
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(iii)a. Elimination of HLA-A, -B, -C
antibodies
It is well established that platelets contain
HLA-A, -B and -C antigens on their surface (ad-
sorbed antigens). Platelets from 20 different
individuals were separated and pooled. The
pooled platelets were used to absorb the anti-
HLA antibodies from the HLA-A, -B positive sera.
The method described by Cambon- Thomsen et
al (9) was followed. In brief, all the HLA-A, -B
positive sera (1µl) were plated in 60 well Terasaki
plates. The pre-dotted walls were added with 1.5
x 106 pooled platelets (10.5 x 109/ml) in 1 µl
saline and stored at -20°C until use.
(iii)b. T and B cell separation
T and B cells from peripheral blood
mononuclear cells were separated by nylon
wooI column adherence method (10). In brief,
 plastic drinking straws approximately 8cm
height were packed with 75 to 100 mg of nylon
wool for 4 to 5 cm height. The columns were
sterilized (10 psi) and used for T and B-cell
separation. The nylon wool columns were
rinsed with TC 199 medium containing 10% foe-
ial calf serum (FCS) and antibiotics. Ap-
proximately 10 - 12 x 106 peripheral Mood
mononulear cells (Ficoll-Hypaque s parated)
in 1 ml medium containing 10% FCS was loaded
on the top of the column and incubated for 45
minutes. Afterwards the nylon wool nonad-
herent cells (enriched T-cell population) were
eluted using 7ml of warm medium. Nylon wool
adherent cells (enriched B-cell population) were
eluted with 5 ml medium by pressing and
squeezing the nylon wool column and used for
HLA-DR and -DQ serological typing.
(iii)c. HLA-DR and -DQ typing in nor-
mal volunteers (for cell panel)
HLA-DR and -DQ typing of normal volunteers
(32 individuals) was performed by two stage NIH
standard microlymphocytotoxicity (antibody de-
pendent complement mediated cytotoxicity)
assay (11). A total number of 38 well defined
HLA-DR and -DQ sera (Biotest, West Germany)
covering DR 1 to DR 9 and DQ 1 to DQ 3 antigen
specificities were used (Table 1).
(iii)d. Screening of sera for HLA-DR
and -DQ antibodies
The plates containing the HLA-A, -B positive
sera (pre- dotted) and pooled platelets were
incubated at room temperature for 1 h with two
or 3 times vortexing; and then the plates were
used for -DR and -DQ antibody screening. For
screening procedure the two stage NIH standard
microlymphocytotoxicity (antibody dependent
complement mediated microlym-
phocytotoxicity) assay was followed (11). In
brief, one µI aliquot containing 2000-3000 (nylon
wool column separated enriched) B-lym-
phocytes was added to each well. The plates
were incubated for 1 h at 25°C; 5 µI of rabbit
complement (absorbed with white cells) was
added and incubated further for another 2 h.
Then the reaction was arrested by adding 5 µl of
3% eosin and neutralized formaldehyde. The
plates were read under phase contrast micro-
scope.
Results
Our earlier reports on the screening of parous
women sera for HLA-A, -B antibodies revealed
59 sera out of the total 1161 to be positive (Table
2) (7,8).
Out of these 59 HLA-A, -B positive sera, 52
were screened presently for HLA-DR and -DQ
antibodies. Out of the 52, only 20 exhibited
positive reaction on B lymphocytes when tested
n the HLA-DR and -DQ typed B cdl panel (32
individuals) (Table 1). Eighteen sera were found
negative and 14 sera still elude exact assignment
warranting further analysis (Table 3).
Out of the 20 HLA-DR and -DQ positive sera,
7 were found to be either monospecific or
duospecific to well defined DR and DQ antigens;
the rest of the sera were multispecific (Table 4).
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Discussion
The present study reveals that the frequency
of HLA-DR and -DQ antibodies is less
(20 + 14 =34, out of 1161 sera) (2.9%) (Table 3)
when compared to the frequency of HLA-ABC
antibodies (5.08%) (7,8) (Table 2).
Further, it also indicates that anti kHIA-DR
and -DC typing reagents can be expected from
multiparous sera (from post- partum blood clots)
containing anti HLA-A or -B antibodies (38.5%;
Table 3). Sera without ABC antibodies have also
been reported to contain HLA-DR and -DR an-
tibodies; however, the frequency of class II an-
tibodies is less in these sera when compared to the
sera that are positive for HLA-ABC antigens (12).
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Table I
Screening of cells (thirty two) for HLA-DR and -DQ antigens (cell panel)
Specificity (number of cells positive)
HLA-DR DR 1 (1); DR 2 (17); DR 3 (4); DR 4 (8); DR 5 (5); DR 6 (2);
DR 7 (12); DR 8 (4); DR blank (11)
HLA-DQ DQ 1 (25); DQ 2 (12); DQ 3 (14); DQ blank (12)
Table 2
Frequency of HLA - A, - B antibodies in parous women sera*
Sera screened for HLA-A, -B, -C antibodies
Positive sera
a) Monospecific sera
   b) Multispecific sera  
Negative sera
*Based on our earlier reports (7,8)
Total sera
1161
59
16
43
1102
Percentage
–
5.08%
1.38%
3.7%
94.9%
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Table 3
Frequency of HLA-DR and -DQ antibodies in HLA-A, -B positive sera of parous women
Sera screened for HLA-DR and -DQ antibodies
Positive sera
Negative sera
Still under analysis for assignment
* HLA-A, -B positive sera of parous women
Total sera Percentage
52* –
20 38.5%
18 34.6%
14 26.9%
Table 4
Analysis on the behaviour of HLA-DR and -DQ positive sera of parous women
Serum Specificity Positive False False Negative r-value
number positive negative
CDM 741 DR 2 15 2 2 11 0.73
CDM 1111 DR3 3 0 1 26 0.84
CDM 1217 DR3 3 0 1 26 0.84
CDM 1501 DR2 13 7 4 6 0.24
CDM 1521 DR 8 2 0 2 26 0.68
CDM 1593 DR 7, DQ 2 8 7 4 11 0.27
CDM 1622 DQ2 6 2 6 16 0.43
